Loading...

Medibio Appoints Global Healthcare & Medical Device Leader as CEO and Managing Director

Medibio Appoints Global Healthcare & Medical Device Leader as CEO and Managing Director   Sydney, Australia and Minneapolis, MN USA – 2 November 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, announces the [...]

2019-03-13T14:01:00-05:00 November 1st, 2018|

Medibio Technology Honored with Two Presentations at Mayo Clinic Convergence Neuroscience 2018

Sydney, Australia and Minneapolis, MN USA – 8 October 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, is happy to announce that two clinical abstracts by Dr. Archie Defillo et al. have been [...]

2018-10-07T19:31:02-05:00 October 7th, 2018|

Medibio Releases Corporate Health Product, ilumen™

Sydney, Australia and Minneapolis, MN USA – 3 October 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, today announced the release of ilumen™, its product and platform for corporate customers. ilumen™ is a [...]

2019-03-13T14:01:41-05:00 October 3rd, 2018|

Medibio Named Finalist for Prestigious Optus My Business Award

The awards are the longest-standing business awards program in Australia, identifying and acknowledging the achievements of Australia’s best business operators. October 1, 2018 | By Medibio Team Sydney, Australia and Minneapolis, MN USA – ​Oct. 01, 2018: Medibio Limited [...]

2018-10-03T13:36:59-05:00 October 1st, 2018|

Medibio Announces Executive Leadership Changes

Medibio Announces Executive Leadership Changes Sydney, Australia and Minneapolis, MN USA – 21 September 2018: The Board of Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), today announced several changes to the Company’s executive leadership team. Medibio is pleased [...]

2018-10-03T13:37:07-05:00 September 21st, 2018|

Medibio Clinical Study Shows Over 20% Improvement to Current Diagnostic Standard

Medibio Clinical Study Shows Over 20% Improvement to Current Diagnostic Standard September 6, 2018 | By Medibio Team Highlights: - Global 230 patient (8 sites) study confirms Medibio’s Depression Diagnostic Aide (DX04) - With 70% accuracy, 70% sensitivity [...]

2018-09-12T16:07:27-05:00 September 6th, 2018|